DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (786)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 786   Next >>

Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: male, weighing 77.2 kg (169.8 pounds)

Reactions: Sepsis, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone

CC-4047
    Dosage: 4 milligram
    Administration route: Oral
    Start date: 2012-05-04
    End date: 2012-05-08

CC-4047
    Dosage: 4 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-12
    End date: 2012-04-16

Clarithromycin
    Dosage: 1000 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-12

CC-4047
    Dosage: 2 milligram
    Administration route: Oral
    Start date: 2012-05-08

CC-4047
    Dosage: 2 milligram
    Administration route: Oral
    Start date: 2012-04-27

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-12

Revlimid
    Dosage: 5 milligram
    Administration route: Oral

Other drugs received by patient: Atenolol; Hydrocortisone; Omega-3 Fatty Acids; Potassium Chloride; Atorvastatin Calcium; Metformin HCL; Amlodipine; Vasotec; Glyburide; Zometa; Prilosec; Magnesium Oxide; Niaspan; Tylenol; Actos; Imodium; Valtrex; Aspirin; Darbepoetin Alfa-Polysorbate; Feosol; Hydrocortisone



Possible Dexamethasone side effects in female

Reported by a physician from Bulgaria on 2012-08-24

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Circulatory Collapse, Bone Marrow Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-23
    End date: 2012-05-25

Doxorubicin Hydrochloride
    Dosage: 80 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-26

Dexamethasone
    Dosage: 40 milligram
    Start date: 2012-06-02
    End date: 2012-06-05

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-30
    End date: 2012-06-07

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-23
    End date: 2012-05-26

Vincristine
    Dosage: 2 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-06-02

Dexamethasone
    Dosage: 20 milligram
    Start date: 2012-05-16
    End date: 2012-05-19

Other drugs received by patient: Milgamma; Dopamine HCL; Nexium; Atropine; Sodium Carbonate; Lyrica; Uromithexane; Electrolyte Infusions; Sodium Bicarbonate; Probitor; Tevagrastim



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Radiation Therapy NOS
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Cisplatin
    Indication: Multiple Myeloma

Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Death, Chalazion

Adverse event resulted in: death

Drug(s) suspected as cause:
Lenalidomide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2009-08-13
    End date: 2012-01-03

Cyclophosphamide
    Indication: Multiple Myeloma

Other drugs received by patient: Bisphosphonates; Travoprost



Possible Dexamethasone side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Ifosfamide
    Start date: 2007-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01



Possible Dexamethasone side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Ifosfamide
    Start date: 2007-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Trabectedin
    Dosage: 1500 microgram per sq meter, q3w
    Indication: Soft Tissue Neoplasm

Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Soft Tissue Neoplasm



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-08-22

Patient:

Reactions: Lung Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 180 mg, qd
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-29
    End date: 2012-05-30

Mabthera
    Dosage: 750 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-29
    End date: 2012-05-29

Velcade
    Dosage: 2.6 mg, qd
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-29
    End date: 2012-06-08

Dexamethasone
    Dosage: 40 mg, unk
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Rocephin; Glucophage; Fasturtec; Lasix; Duphalac; Colchicine; Actrapid / 00030501 /; Xanax; Ventolin; Albumin; Atarax; Nexium; Zelitrex / 01269701 /; Tranxene; Bactrim; Imovane; Magnesium Sulfate; Ramipril; Citalopram Hydrobromide; Folic Acid; Oxazepam; Pentoxifylline; Lasix



Possible Dexamethasone side effects in 59 year old female

Reported by a physician from United States on 2012-08-22

Patient: 59 year old female, weighing 67.8 kg (149.1 pounds)

Reactions: Embolism, Muscular Weakness, Gastric Haemorrhage, Cardiac Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 0.22 mg/kg, cyclic
    Administration route: Oral
    Indication: Amyloidosis
    Start date: 2012-07-09
    End date: 2012-08-09

Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Amyloidosis
    Start date: 2012-07-09
    End date: 2012-08-09

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Amyloidosis
    Start date: 2012-07-09
    End date: 2012-08-09

Velcade
    Dosage: 1.3 mg/m2, cyclic



Possible Dexamethasone side effects in 82 year old male

Reported by a consumer/non-health professional from United Kingdom on 2012-08-22

Patient: 82 year old male

Reactions: Flushing, Malaise, Feeling Hot, Chills, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 70 mg/m2, qd
    Start date: 2011-08-09

Bendamustine Hydrochloride
    Dosage: 70 mg/m2, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-13
    End date: 2011-06-14

Dexamethasone
    Dosage: 20 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-02

Bendamustine Hydrochloride
    Dosage: 70 mg/m2, qd
    Start date: 2011-07-11

Other drugs received by patient: Ciprofloxacin HCL; Prilosec; Fluconazole; Acyclovir; Ramipril; Omeprazole; Allopurinol Sodium; Enoxaparin Sodium; Simvastatin; Aspirin



Possible Dexamethasone side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-21

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Ifosfamide
    Start date: 2007-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Bleomycin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01



Possible Dexamethasone side effects in 45 year old female

Reported by a physician from United States on 2012-08-21

Patient: 45 year old female

Reactions: Epstein-Barr Virus Infection, Splenic Infection Fungal, Mycosis Fungoides Refractory, Granuloma, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fludara
    Dosage: 2 cycles
    Indication: Mycosis Fungoides

Campath
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-06-01

Etoposide
    Dosage: unk
    Indication: Mycosis Fungoides

Dexamethasone
    Dosage: unk
    Indication: Mycosis Fungoides

Vincristine
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01

Cisplatin
    Dosage: unk
    Indication: Mycosis Fungoides

Cyclophosphamide
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01

Prednisone
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01

Ifosfamide
    Dosage: unk
    Indication: Mycosis Fungoides

Daunorubicin HCL
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01



Possible Dexamethasone side effects in 77 year old male

Reported by a health professional (non-physician/pharmacist) from China on 2012-08-21

Patient: 77 year old male

Reactions: Adverse Drug Reaction, Diffuse Large B-Cell Lymphoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisone
    Dosage: on days 1 to 5
    Indication: Diffuse Large B-Cell Lymphoma

Methotrexate
    Dosage: in cycle 1
    Indication: Diffuse Large B-Cell Lymphoma

Dexamethasone
    Dosage: in cycle 1
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: on day 1
    Indication: Diffuse Large B-Cell Lymphoma



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: on day 1 over 15-30 minutes
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Hypoxia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: female

Reactions: Hyperglycaemia, Malnutrition, Fall, Hepatic Enzyme Increased, Neoplasm Malignant, Oral Candidiasis, Oedema Peripheral, Urosepsis, Pulmonary Oedema, Asthenia, Acute Respiratory Failure, Escherichia Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 4 mg, bid
    Indication: Metastases To Central Nervous System
    Start date: 2012-05-02

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2012-05-31

Dexamethasone
    Dosage: unk

Other drugs received by patient: Folic Acid; Provera; Duragesic-100; Celexa; Clarinex / 01202601 /; Estrace; Flexeril; Xanax; Fluticasone Propionate; Pepcid; Vicodin; Keppra; Compazine



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from Germany on 2012-08-20

Patient:

Reactions: Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2012-03-26
    End date: 2012-07-05

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2012-03-26
    End date: 2012-07-05

Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2012-03-26
    End date: 2012-07-05

Other drugs received by patient: Zometa; Amoxicillin



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Hypoxia, Pleural Effusion

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: 68 year old female, weighing 88.0 kg (193.6 pounds)

Reactions: Dyspnoea, Pneumonia, Urinary Tract Infection, Constipation, Disease Progression, Multi-Organ Failure, Hypothyroidism, Gastrooesophageal Reflux Disease, Candidiasis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 8 mg
    Administration route: Oral
    Indication: Palliative Care
    Start date: 2011-07-05

Crizotinib
    Dosage: 500 mg
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-07-26
    End date: 2011-08-16

Other drugs received by patient: Calcium; Vicoprofen; Levothyroxine Sodium; Prochlorperazine; Omeprazole; Albuterol; Oxycontin; Ondansetron; Lactulose; Folic Acid; Atorvastatin; Colace; Clonazepam



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-17

Patient:

Reactions: Off Label Use, Hypoxia, Pleural Effusion, Bacterial Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: on days 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: by push day 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: (pegylated) 2500 units/ m2/ dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: on day 15 and triple therapy on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: divided into 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 and as cns involvement on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-17

Patient:

Reactions: Vomiting, Cardio-Respiratory Arrest, International Normalised Ratio Increased, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-07-03
    End date: 2012-07-13

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-07-03
    End date: 2012-07-14

Other drugs received by patient: Carvedilol; Omeprazole; Calcium; Acenocoumarol; Candesartan Cilexetil; Prednisone TAB; Furosemide; Folic Acid; Movicol / 01053601 /



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-08-16

Patient:

Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Metabolic Acidosis, Hypotension, Blood Calcium Increased, Mental Status Changes, Multiple Myeloma, Hepatic Encephalopathy, Respiratory Failure, Ammonia Increased, Depressed Level of Consciousness, Thrombocytopenia, Hallucination, Epistaxis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-24
    End date: 2012-06-02

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-24
    End date: 2012-06-02

Other drugs received by patient: Cholecalciferol; Metoprolol Tartrate; Sucralfate; Levalbuterol HCL; Dextrose 5%; Pantoprazole; Morphine; Fluconazole; Mepron; Metformin Hydrochloride; Aspirin; Metoprolol Tartrate; Omeprazole; Rosuvastatin; Clindamycin; Lyrica; Valacyclovir Hydrochloride; Xyloxylin; Lactulose; Tramadol HCL; Insulin



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male, weighing 82.4 kg (181.3 pounds)

Reactions: Myocardial Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-15
    End date: 2012-07-09

Carfilzomib
    Dosage: 38 milligram
    Indication: Multiple Myeloma
    Start date: 2011-08-15

Carfilzomib
    Start date: 2012-04-23
    End date: 2012-07-30

Dexamethasone
    Start date: 2012-04-02
    End date: 2012-06-11

Carfilzomib
    Start date: 2011-08-22

Carfilzomib
    Start date: 2011-12-05

Carfilzomib
    Start date: 2012-02-27

Carfilzomib
    Start date: 2011-09-12

Dexamethasone
    Start date: 2011-12-05

Dexamethasone
    Start date: 2012-03-26

Carfilzomib
    Start date: 2012-01-03

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2011-08-15

Dexamethasone
    Start date: 2011-11-28

Other drugs received by patient: Vicodin; Warfarin Sodium; Warfarin Sodium; Carvedilol; Lasix; Zometa; Carvedilol; Potassium Chloride; Compazine; Lasix; Valacyclovir Hydrochloride; Calcium; Metformin Hydrochloride; Omeprazole



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014